Gene therapy finds its niche

@article{Sheridan2011GeneTF,
  title={Gene therapy finds its niche},
  author={Cormac Sheridan},
  journal={Nature Biotechnology},
  year={2011},
  volume={29},
  pages={121-128}
}
  • C. Sheridan
  • Published 2011
  • Biology, Medicine
  • Nature Biotechnology
Gene therapy is finally poised to make a contribution to the treatment of debilitating, highly penetrant genetic diseases that have proved intractable to other regimens. 

Figures, Tables, and Topics from this paper

Gene therapy on the move 1642 Gene therapy on the move
The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
Production of lentiviral vectors for gene therapy
TLDR
This research presents a novel and scalable approach to cell reprograming that allows for real-time decision-making in the rapidly changing environment and has the potential to improve the quality of life of patients. Expand
Gene Therapy in the Developing Countries
TLDR
This review throws more light on gene therapy, its application and consequences in the developing countries. Expand
Gene Therapy for Melanoma: Progress and Perspectives
TLDR
This chapter will attempt to answer the question of is gene therapy a viable option for the treatment of melanoma patients by exploring the intersection between the technology of gene therapy and the biology of melan cancer, a point at which opportunities for intervention are revealed. Expand
State-of-the-art gene-based therapies: the road ahead
  • M. Kay
  • Biology, Medicine
  • Nature Reviews Genetics
  • 2011
Improvements in the gene transfer vectors used in therapeutic trials have led to substantial clinical successes in patients with serious genetic conditions, such as immunodeficiency syndromes,Expand
Applications of Gene Editing Technologies to Cellular Therapies.
TLDR
CRISPR/Cas9 technology has been applied to various hematologic malignancies and has also been used to modify and improve chimeric antigen receptor-modified T cells for the purpose of providing effective cellular therapies. Expand
Recent Progresses in Brain Gene Therapy
TLDR
This review tried to focus on techniques and approaches in brain tumors and nervous system’s gene therapy strategies and will discuss about associated problems and potential future in management of inherited or acquired neurological disorders. Expand
Cell-Based Gene Therapy
TLDR
Three critical aspects have emerged for all gene transfer approaches which are also fundamental to further develop this novel and highly sophisticated therapy. Expand
Cell type specific gene delivery by lentiviral vectors
TLDR
Recent findings about a CD8-specific vector that enhances the killing of tumor cells in TCR-based gene transfer strategies are explained. Expand
Gene Therapy in the Management of Head and Neck Cancers: A Review. -
TLDR
Different treatment approaches are revealed for cancer gene therapy; gene addition therapy, suicide gene therapy, immunotherapy, and different types of gene therapies are discussed along with an insight into future of this treatment modality. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
20 years of gene therapy for SCID
TLDR
The past 20 years has shown that severe combined immunodeficiency conditions are correctable by gene therapy, and these diseases were initially treated by transplantation of allogeneic hematopoietic stem cells. Expand
Gene therapy: cursed or inching towards credibility?
  • M. Branca
  • Biology, Medicine
  • Nature Biotechnology
  • 2005
TLDR
A chastened but determined group of pioneers believes gene therapy can be lived down and live up to its initial promise, and they are pointing to a new generation of products to back up that claim. Expand
T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years
TLDR
It is concluded here that gene therapy can be a safe and effective addition to treatment for some patients with this severe immunodeficiency disease. Expand
Splicing Out the West?
CHINESE GENE THERAPYBEIJING-- Chinese researchers have been the first to put cancer gene-therapy products on the market, but critics question the data behind the success stories. ([Read more][1].) Expand
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
TLDR
Gene therapy, combined with reduced-intensity conditioning, is a safe and effective treatment for SCID in patients with ADA deficiency and effective protection against infections and improvement in physical development made a normal lifestyle possible. Expand
A brief history of gene therapy
TLDR
Efficient retroviral vectors and other gene transfer methods have permitted convincing demonstrations of efficient phenotype correction in vitro and in vivo, now making gene therapy a broadly accepted approach to therapy and justifying clinically applied studies with human patients. Expand
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.
TLDR
A gene therapy trial for SCID-X1 was initiated, based on the use of complementary DNA containing a defective gammac Moloney retrovirus-derived vector and ex vivo infection of CD34+ cells, which provided full correction of disease phenotype and clinical benefit. Expand
Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes.
TLDR
The data suggest that this lentiviral vector may provide a step change in airway transduction efficiency relevant to a clinical programme of gene therapy for CF. Expand
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
TLDR
Using a CpG-free pDNA expression vector, sustained in vivo transgene expression is achieved in the absence of lung inflammation and it is demonstrated that retention of even a single CPG in pDNA is sufficient to elicit an inflammatory response, whereas C pG- free pDNA vectors do not. Expand
Gene Therapy for Human Genetic Disease?
TLDR
A sustained effort is proposed to be made to formulate a complete set of ethicoscientific criteria to guide the development and clinical application of gene therapy techniques, which could go a long way toward ensuring that gene therapy is used in humans only in those instances where it will prove beneficial, and toward preventing its misuse through premature application. Expand
...
1
2
...